artificial intelligence summit in pharmaceutical industry 2019
artificial intelligence summit in pharmaceutical industry 2019
Regulated pharma teams do not struggle with a lack of ideas; they struggle with documentation, validation, and getting good outcomes without adding risk. The artificial intelligence summit in pharmaceutical industry 2019 mattered because it helped shift the conversation from “cool demos” to practical ways to improve quality, regulatory work, and clinical operations. If you work in pharma, the real question is not whether AI is possible, but how to use it safely, ethically, and consistently.
On this page you will find practical lessons you can still apply today, inspired by the artificial intelligence summit in pharmaceutical industry 2019, plus clear ways to build competence in your team through consulting, coaching, and workshops.
Go to consulting | Go to coaching | Go to workshop | Go to contact
Why artificial intelligence summit in pharmaceutical industry 2019 still matters in regulated pharma work
The artificial intelligence summit in pharmaceutical industry 2019 arrived at a turning point: pharma was already data-rich, but many teams were still operating with manual, copy-paste workflows across regulatory, quality, and clinical operations. The most valuable takeaway was not “use a specific tool”, but “build capability and governance so AI can be used repeatedly and compliantly”.
In practice, this means competence development over tool features. A compliant AI workflow is usually a mix of:
- Clear use cases tied to outcomes (faster cycle time, fewer deviations, better inspection readiness).
- Human accountability (review, approval, traceability).
- Quality thinking (risk assessment, validation where needed, controlled documentation).
- Practical habits that people can use in daily work, not just in pilots.
If you want examples of how pharma is applying AI across domains, you can also explore: AI and pharma, artificial intelligence pharma, and pharmaceutical industry and ai.
Typical barriers when implementing AI after the artificial intelligence summit in pharmaceutical industry 2019
Many organizations left events like the artificial intelligence summit in pharmaceutical industry 2019 inspired, but then hit the same obstacles. These challenges are normal, and they can be handled with the right structure.
- Unclear “what good looks like”. Teams start with broad ambitions instead of a single workflow (e.g., MLR comment resolution, deviation triage, protocol authoring support).
- Compliance uncertainty. People worry about data privacy, model output reliability, and what can be used in GxP contexts.
- Fragmented ownership. IT, quality, regulatory, and business functions each wait for the other to define rules.
- Low confidence in daily use. Even when tools exist, employees do not know how to prompt, verify, or document AI-assisted work.
- Weak content readiness. SOPs, templates, and knowledge bases are inconsistent, making it hard to reuse approved language safely.
- Pilot fatigue. Short pilots do not translate into habits, so benefits disappear after the initial enthusiasm.
To ground your approach, you may find it helpful to review related topics such as ai in pharmaceutical compliance, ai in pharmaceutical validation, and ai governance pharmaceutical industry.
Six practical lessons you can apply from artificial intelligence summit in pharmaceutical industry 2019
Start with a regulated workflow, not a tool
The strongest results come when AI supports a specific, repeatable workflow with clear inputs and outputs. For example, in regulatory affairs you can use AI to draft a structured first version of a response letter, then require a human reviewer to verify claims, citations, and labeling language before approval. This approach aligns with the mindset that gained traction around the artificial intelligence summit in pharmaceutical industry 2019.
Define “safe use” in writing, in plain language
People move faster when rules are simple. Define what data is allowed, what is prohibited, and how to document AI assistance. In quality, a practical rule could be: “AI may summarize deviation narratives for triage, but root cause and CAPA decisions must be made and documented by trained personnel.” This is how you turn interest from the artificial intelligence summit in pharmaceutical industry 2019 into daily, compliant practice.
Make verification a skill, not an afterthought
In clinical operations, an AI-generated site communication draft can save time, but only if staff know how to verify critical details (visit windows, protocol references, country-specific constraints). Verification is a learnable skill: checklists, source linking, and structured peer review reduce risk without slowing teams down.
Build reusable templates for common pharma documents
Pharma work repeats: risk assessments, change controls, validation summaries, SOP updates, training materials, and medical/legal review comments. When you standardize templates, AI becomes more consistent and easier to review. This also improves inspection readiness because outputs follow an approved structure. For more on the broader landscape, see pharmaceutical industry software and software for pharmaceutical.
Choose measurable outcomes that matter to leadership
AI initiatives stall when benefits are described vaguely. Choose operational measures such as cycle time reduction in document preparation, fewer rework loops in MLR, faster deviation triage, or improved consistency in training content. Linking outcomes to real constraints is a core theme many teams took from the artificial intelligence summit in pharmaceutical industry 2019.
Invest in competence development across functions
AI adoption becomes sustainable when regulatory, quality, clinical, and commercial teams share a common baseline: what AI can do, how to use it safely, and how to document work. This competence-first approach supports ethical use and reduces reliance on a small group of “AI champions”. If you want to explore capability areas, see ai ml in pharmaceutical industry and ai courses for pharmaceutical industry.
Where AI helps most in pharma: practical examples
The artificial intelligence summit in pharmaceutical industry 2019 highlighted many use cases, but the most durable ones are still the “everyday” workflows:
- Regulatory: drafting structured document sections, comparing variations, summarizing guidance, preparing response frameworks (with human verification).
- Quality: deviation and complaint triage summaries, trend analysis support, audit preparation checklists, controlled language suggestions.
- Clinical operations: protocol synopsis support, site communication drafts, issue log summarization, query pattern analysis.
- Commercial and marketing: compliant-first content drafts, localization support, message testing hypotheses (within MLR rules).
Further reading for your team: ai in pharma news, ai in pharma marketing, ai in pharmaceutical research and development, and artificial intelligence in pharmaceutical regulatory affairs.
Consulting (€1,480)
Consulting is for pharma leaders and specialists who want a clear, compliant path from idea to daily practice. The goal is to reduce uncertainty and create momentum with pragmatic decisions on use cases, governance, and implementation steps.
- What you get: help selecting high-value workflows, defining safe-use rules, and setting up practical operating routines.
- Typical outcomes: clearer ownership, fewer stalled pilots, and faster adoption with less risk.
- Best for: teams starting AI in regulated processes or scaling from pilot to standard work.
To map your next steps, you can also review: ai implementation in pharmaceutical industry and ai adoption for pharmaceutical.
1-on-1 coaching (€2,400)
This 1-on-1 coaching is designed to grow your skills and confidence so you can use AI in your daily work without compromising compliance. It is practical, tailored, and focused on building habits that stick.
- What you get: 10 hours of personal coaching, split into flexible sessions.
- Work on your real tasks: regulatory writing, quality documentation, clinical operations support, and internal communication.
- Ongoing support: by email or online chat between sessions.
- Clear progress: practical takeaways from each session.
- Price: €2,400 for a 10-hour bundle (ex. VAT).
If you want a structured competence path aligned with themes that emerged after the artificial intelligence summit in pharmaceutical industry 2019, coaching is often the fastest route.
Workshop (€2,600)
This hands-on workshop trains pharma professionals to use AI tools in their own work, with a strong focus on safe, ethical, and effective use. The tone is non-technical, and the exercises are built around real pharma tasks.
- What you get: a practical introduction to tools like ChatGPT, Copilot, and Perplexity.
- Customized exercises: based on participants’ roles (e.g., clinical, quality, admin).
- Tools you can reuse: prompt patterns, checklists, and documentation habits that fit regulated work.
- Compliance focus: safe use, ethical boundaries, and review discipline.
- Price: from €2,600 (ex. VAT) for a 3-hour session with up to 25 participants.
Workshops are ideal when you want shared language and consistent ways of working, which is exactly what many organizations lacked after the artificial intelligence summit in pharmaceutical industry 2019.
Recommended internal resources for deeper learning
- graph of pharmaceutical industry in ai
- generative ai in pharma and generative ai pharma
- generative ai in the pharmaceutical industry and generative ai for pharmaceuticals
- ai pharma companies and ai pharmaceutical company
- ai agency for pharma and ai solutions for pharmaceutical industry
- ai in pharmaceutical sciences and artificial intelligence in pharmaceutical sciences
- impact of ai on pharmaceutical industry and future of ai in pharmaceutical industry
- challenges of ai in pharmaceutical industry and disadvantages of ai in pharmaceutical industry
Kontakt
If you want to turn lessons from the artificial intelligence summit in pharmaceutical industry 2019 into compliant, repeatable ways of working, get in touch. We will focus on your workflows, your risk profile, and your team’s competence development.
Email: kasper@pharmaconsulting.ai
Phone: +45 2442 5425
Konsulentbistand | Coaching | Workshop
When you are ready, share one workflow you want to improve (regulatory, quality, or clinical operations), and we will suggest a safe first step that your team can actually adopt.
